<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146132">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01691586</url>
  </required_header>
  <id_info>
    <org_study_id>UMCU.DHL.001</org_study_id>
    <nct_id>NCT01691586</nct_id>
  </id_info>
  <brief_title>Patient Perspective on Remote Monitoring of Cardiovascular Implantable Electronic Devices</brief_title>
  <acronym>REMOTE-CIED</acronym>
  <official_title>Remote Monitoring of Heart Failure Patients With Cardiovascular Implantable Electronic Device: The Patient Perspective</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Tilburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>UMC Utrecht</source>
  <oversight_info>
    <authority>Netherlands: Medical Ethics Review Committee (METC)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A relatively new and promising development in the area of cardiovascular implantable
      electronic device therapy is remote patient monitoring (RPM). RPM systems can interrogate
      the device automatically and send the data from the patients' home to the physician, thereby
      reducing in-clinic follow-ups.

      The purpose of this study is to evaluate the effect of RPM + in-clinic follow-up versus
      in-clinic follow-up only on patient-reported health status and device-acceptance after
      implantation with an implantable cardioverter defibrillator (ICD) or cardiac
      resynchronization defibrillator (CRT-D).

      Secondary objectives are (1) to identify subgroups of patients who prefer RPM over in-clinic
      visits or vice versa due to specific clinical and psychological factors and (2) To
      investigate the cost-effectiveness of RPM + in-clinic follow-up compared to in-clinic
      follow-up only.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Patient-reported health status</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>23-item Kansas City Cardiomyopathy Questionnaire (KCCQ)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient-reported device acceptance</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>12-item Florida Patient Acceptance Scale (FPAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient-reported satisfaction with care</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Visual Analogue Scale ranging from 0-100 (with higher score representing more satisfaction with care)
26-item self-made questionnaire to assess satisfaction with RPM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Data regarding health care utilization is gathered from hospitals and patients.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>RPM</arm_group_label>
    <description>RPM + in-clinic follow-up</description>
  </arm_group>
  <arm_group>
    <arm_group_label>In-Clinic</arm_group_label>
    <description>In-clinic follow-up</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Heart failure patients implanted with a first-time ICD/CRT-D device at one of the
        participating centers.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  first time ICD/CRT-D implanted at one of the participating centers

          -  left ventricular ejection fraction &lt;35%

          -  NYHA functional class II or III symptoms

          -  ICD/CRT-D device compatible with the LATITUDE(r) RPM system from Boston Scientific

        Exclusion Criteria:

          -  On the waiting list for heart transplantation

          -  History of psychiatric illness others than affective/anxiety disorders

          -  Cognitive impairments

          -  Insufficient knowledge of the language to fill in the questionnaires
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathias Meine, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathias Meine, Dr</last_name>
    <phone>+31 (0)88 466 6184</phone>
    <email>mmeine@umcutrecht.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Medical Center Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathias Meine, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 18, 2013</lastchanged_date>
  <firstreceived_date>September 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UMC Utrecht</investigator_affiliation>
    <investigator_full_name>M. Meine</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>implantable defibrillators</keyword>
  <keyword>remote patient monitoring</keyword>
  <keyword>patient-reported outcomes</keyword>
  <keyword>cost-effectiveness</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
